drugset / Trial / NCT02604537

Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis

NCT02604537

Phase 4 Completed 62 enrolled OrthoCarolina Research Institute, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if corticosteroid injection modifies the natural course of de Quervain tendinopathy compared to a toradol injection.

Timeline

Start
2015-10-15
Primary completion
2024-10-01
Completion
2024-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified 6 mg Other
Subject Ketorolac Other / unclassified 30 mg Other

Indications